© Synexa Life Sciences BV 2025
Blogs
- Resources
- Blogs
Latest Blogs
From Pathways to Proof: Targeted Phosphoproteomics and PTM Analysis with LC-MS/MS
Quadrupole mass spectrometry (LC-MS/MS) has long established itself as the workhorse of bioanalysis for small molecules, valued for its high sensitivity, selectivity, and robustness in…
18 Jun, 2025 | Blogs
Video
Identifying biomarkers of success: Integrated bioanalysis for glioblastoma CAR-T cell clinical trials
Glioblastoma remains one of the most aggressive and treatment-resistant cancers. Standard therapies often fail, leaving patients with limited options.…
18 Oct, 2024 | Blogs
Video
Allogeneic CAR T cell therapies: A major step forward
In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…
09 Oct, 2024 | Blogs
Video
A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology
Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…
17 Sep, 2024 | Blogs
Video
The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers
Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…
05 Sep, 2024 | Blogs
Video
The STING in the tail: How our own defense mechanisms to infection may be working against us
In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…
29 Aug, 2024 | Blogs
Video
Falling drug approval rates: What should we be doing differently?
Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…
06 Aug, 2024 | Blogs
